ursodeoxycholic acid has been researched along with Bile Duct Diseases in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (13.89) | 18.7374 |
| 1990's | 13 (36.11) | 18.2507 |
| 2000's | 10 (27.78) | 29.6817 |
| 2010's | 8 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brackett, LM; Reddy, CA; Schneider, BJ; Tai, AW | 1 |
| García-Pajares, F; Madrigal Rubiales, B; Tejedor-Tejada, J | 1 |
| Beuers, U; Herta, T | 1 |
| Aglietta, M; Boccone, P; Caravelli, D; Carnevale Schianca, F; D'Ambrosio, L; De Rosa, G; Grignani, G; Manca, A; Nuzzo, A; Rota Scalabrini, D; Tolomeo, F | 1 |
| Claudel, T; Fickert, P; Fuchs, C; Halilbasic, E; Hofer, H; Kazemi-Shirazi, L; Kienbacher, C; Krones, E; Moustafa, T; Munda, P; Paumgartner, G; Pollheimer, M; Steinacher, D; Trauner, M; Traussnigg, S | 1 |
| Hujdurovic, A; Kurtcehajic, A; Vele, E | 1 |
| Geier, A; Tischendorf, JJ; Trautwein, C | 1 |
| Beuers, U; Göke, B | 1 |
| Chen, GQ; Deng, GL; Lu, LG; Peng, ZH; Tang, HM; Wang, SY; Wang, ZW; Xing, TH; Xu, JM; Zhong, L | 1 |
| Choi, JS; Ha, SI; Jo, YG; Jun, HS; Kim, YH; Lee, SH; Lee, WH; Park, SG | 1 |
| Chiba, T; Fukai, K; Imazeki, F; Kanda, T; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O | 1 |
| Alvarez, E; Bañares, R; Barrio, J; Clemente, G; de Diego, A; Núñez, O; Palomo, J; Pérez Calle, JL; Salcedo, M | 1 |
| Chazouillères, O; Wendum, D | 1 |
| Geubel, AP; Rahier, J; Sempoux, C | 1 |
| Gilbert-Barness, E; González-Peralta, RP; Ignacio, JR; Kaiser, GC; Lacson, AG; Smith, LA; Wilsey, MJ; Winesett, MP | 1 |
| Beuers, U; Pusl, T | 1 |
| Lugli, R; Salati, R; Salvioli, G; Zanni, C | 1 |
| Goszcz, A | 1 |
| Mok, HY; Pimstone, NR | 1 |
| Tanner, MS; Taylor, CJ | 1 |
| Bendayan, M; Lambert, M; Levy, E; Paradis, K; Thibault, L | 1 |
| Alvarez, F; Colombato, LA; Côté, J; Huet, PM | 1 |
| Bianchi, L; Bru, C; Bruguera, M; Gilabert, R; Navarro, S; Ros, E | 1 |
| Couse, NF; Delaney, CP; Gorey, TF | 1 |
| Ansari, GG; Cosentino, CM; Das, JB; Levy, MF; Raffensperger, JG | 1 |
| O'Brien, CB; Reddy, KR; Saul, SH; Shields, DS | 1 |
| Benkerrou, M; de Graeff-Meeder, BR; Fischer, A; Haddad, E; Patey, N; Spliet, WG; Wulffraat, NM | 1 |
| Arenas, JI; Arrizabalaga, J; Castiella, A; Iribarren, JA; López, P; Rodríguez, F; von Wichmann, MA | 1 |
| Jonas, MM; Perez-Atayde, A; Srivastava, M | 1 |
| Berenguer Lapuerta, J; Pérez-Aguilar, F | 1 |
| Gores, GJ; Lazaridis, KN; Lindor, KD | 1 |
| Anan'eva, NP; Drondina, AK; Nikitina, TS; Reĭzis, AR; Stulov, AP | 1 |
| Sugata, F | 1 |
| Bayard, F; Buscail, LE; Delvaux, MM; Escourrou, JR; Harris, AG; Puel-Bousquet, C; Ribet, A; Tauber, JP; Vaysse, NM | 1 |
| Fromm, H; Malavolti, M | 1 |
| Poupon, R | 1 |
15 review(s) available for ursodeoxycholic acid and Bile Duct Diseases
| Article | Year |
|---|---|
[Immune-mediated cholangiopathies : Diagnostic and therapeutic challenges].
Topics: Bile Duct Diseases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2019 |
Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Diseases; Female; Hodgkin Disease; Humans; Paraneoplastic Syndromes; Prednisone; Remission Induction; Ursodeoxycholic Acid | 2014 |
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders.
Topics: Animals; Bile Duct Diseases; Humans; Liver Diseases; Metabolic Diseases; Signal Transduction; Ursodeoxycholic Acid | 2015 |
Current diagnosis and management of primary sclerosing cholangitis.
Topics: Algorithms; Bile Duct Diseases; Bile Duct Neoplasms; Cholangiocarcinoma; Cholangitis, Sclerosing; Constriction, Pathologic; Endoscopy; Gastroenterology; Humans; Liver Transplantation; Prognosis; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid | 2008 |
[Diseases of the intrahepatic bile duct: diagnosis and principles of treatment].
Topics: Adult; Algorithms; Antibodies, Antineutrophil Cytoplasmic; Bile Duct Diseases; Bile Ducts, Intrahepatic; Biomarkers; Biopsy, Needle; Causality; Child; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Decision Trees; Diagnosis, Differential; Disease Progression; Humans; Liver Transplantation; Magnetic Resonance Imaging; Sensitivity and Specificity; Ursodeoxycholic Acid | 2003 |
Bile duct disorders.
Topics: Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antiviral Agents; Bile Duct Diseases; Cholagogues and Choleretics; Cholestasis; Drug Therapy, Combination; Humans; Radiotherapy; Ursodeoxycholic Acid | 2003 |
Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
Topics: Apoptosis; Bile Acids and Salts; Bile Duct Diseases; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis; Liver Failure; Syndrome; Ursodeoxycholic Acid | 2006 |
[Ursodeoxycholic acid (UDCA) in the treatment of cholesterol cholelithiasis of the gallbladder and bile ducts].
Topics: Anticholesteremic Agents; Bile; Bile Duct Diseases; Cholelithiasis; Cholesterol; Deoxycholic Acid; Drug Evaluation; Humans; Ursodeoxycholic Acid | 1983 |
Current status of medical treatment of gallstones.
Topics: Bile Duct Diseases; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholelithiasis; Diet; Drug Combinations; Humans; Monoterpenes; Oils, Volatile; Terpenes; Ursodeoxycholic Acid | 1981 |
Liver disease in cystic fibrosis.
Topics: Adolescent; Adult; Bile Duct Diseases; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Susceptibility; Genetic Therapy; Humans; Liver Diseases; Membrane Proteins; Ursodeoxycholic Acid | 1995 |
Evolving management of biliary tract disease.
Topics: Aged; Bile Duct Diseases; Chenodeoxycholic Acid; Cholecystectomy, Laparoscopic; Cholelithiasis; Gallstones; Humans; Lithotripsy; Stents; Ursodeoxycholic Acid | 1993 |
Drug-induced vanishing bile duct syndrome: response to ursodiol.
Topics: Antipsychotic Agents; Bile Duct Diseases; Cholagogues and Choleretics; Cholestasis; Chronic Disease; Female; Humans; Liver Function Tests; Middle Aged; Prochlorperazine; Syndrome; Ursodeoxycholic Acid | 1996 |
[Hepatobiliary disease in cystic fibrosis].
Topics: Bile Duct Diseases; Biomarkers; Cholagogues and Choleretics; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Liver Diseases; Ursodeoxycholic Acid | 1998 |
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.
Topics: Animals; Bile Duct Diseases; Chemical Phenomena; Chemistry, Physical; Humans; Liver Diseases; Ursodeoxycholic Acid | 2001 |
Dissolving gallstones.
Topics: Bile Duct Diseases; Caprylates; Chenodeoxycholic Acid; Cholelithiasis; Deoxycholic Acid; Ethers; Glycerides; Humans; Lithotripsy; Methyl Ethers; Solvents; Ursodeoxycholic Acid | 1988 |
2 trial(s) available for ursodeoxycholic acid and Bile Duct Diseases
| Article | Year |
|---|---|
Effect of ursodeoxycholic acid administration after liver transplantation on serum liver tests and biliary complications: a randomized clinical trial.
Topics: Bile; Bile Acids and Salts; Bile Duct Diseases; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Double-Blind Method; Graft Survival; Humans; Liver Function Tests; Liver Transplantation; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
Medical treatment of biliary duct stones: effect of ursodeoxycholic acid administration.
Topics: Adolescent; Adult; Aged; Bile; Bile Acids and Salts; Bile Duct Diseases; Cholelithiasis; Cholesterol; Clinical Trials as Topic; Deoxycholic Acid; Double-Blind Method; Female; Humans; Male; Middle Aged; Random Allocation; Ursodeoxycholic Acid | 1983 |
19 other study(ies) available for ursodeoxycholic acid and Bile Duct Diseases
| Article | Year |
|---|---|
Nivolumab-induced large-duct cholangiopathy treated with ursodeoxycholic acid and tocilizumab.
Topics: Adenocarcinoma of Lung; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Bile Duct Diseases; Cholagogues and Choleretics; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunotherapy; Lung Neoplasms; Middle Aged; Nivolumab; Treatment Outcome; Ursodeoxycholic Acid | 2019 |
Hepatobiliary and Pancreatic: Sertraline-induced vanishing bile duct syndrome treated with plasmapheresis.
Topics: Adult; Bile Duct Diseases; Bile Ducts, Intrahepatic; Chemical and Drug Induced Liver Injury; Female; Humans; Plasmapheresis; Selective Serotonin Reuptake Inhibitors; Sertraline; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2019 |
Portal vein aneurysm and portal biliopathy.
Topics: Abdominal Pain; Aged; Aneurysm; Bile Duct Diseases; Cholangiopancreatography, Magnetic Resonance; Constriction, Pathologic; Contrast Media; Female; Follow-Up Studies; Hepatic Duct, Common; Humans; Portal Vein; Rare Diseases; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome; Ursodeoxycholic Acid; Vascular Malformations | 2016 |
GLP-1 analogues: a new therapeutic approach to prevent ductopenia in cholangiopathies?
Topics: Bile Duct Diseases; Cell Proliferation; Exenatide; Glucagon-Like Peptide 1; Humans; Incretins; Peptides; Ursodeoxycholic Acid; Venoms | 2009 |
[Biliary cast syndrome in non-liver surgery patients].
Topics: Acute Disease; Ascariasis; Bile Duct Diseases; Bile Ducts; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Female; Gallstones; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Pancreatitis; Tomography, X-Ray Computed; Ultrasonography; Ursodeoxycholic Acid | 2012 |
Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid.
Topics: Acute Disease; Adult; Bile Duct Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Graft vs Host Disease; Hepatitis; Humans; Immunosuppressive Agents; Liver Cirrhosis; Male; Prednisolone; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
[Cytomegalovirus hepatitis and ductopenia in a heart transplant recipient].
Topics: Acute Disease; Antiviral Agents; Azathioprine; Bile Duct Diseases; Bile Ducts, Intrahepatic; Cytokines; Cytomegalovirus Infections; Drug Therapy, Combination; gamma-Globulins; Ganciclovir; Graft Rejection; Heart Transplantation; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Models, Biological; Mycophenolic Acid; Postoperative Complications; Ursodeoxycholic Acid | 2003 |
Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bile Duct Diseases; Child; Cholestasis, Intrahepatic; Humans; Male; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
Lipoprotein abnormalities in two children with minimal biliary excretion.
Topics: Alagille Syndrome; Bile Acids and Salts; Bile Duct Diseases; Child, Preschool; Cholestasis; Cholesterol; Humans; Infant; Lipid Metabolism; Lipids; Lipoprotein-X; Lipoproteins; Male; Ursodeoxycholic Acid | 1995 |
Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?
Topics: Antibodies, Antinuclear; Autoantibodies; Autoantigens; Autoimmune Diseases; Bile Duct Diseases; Female; Fluorescent Antibody Technique; Follow-Up Studies; Hepatitis; Humans; Immunoblotting; Liver Cirrhosis, Biliary; Middle Aged; Mitochondria, Liver; Prednisone; Ursodeoxycholic Acid | 1994 |
Ursodeoxycholic acid treatment of primary hepatolithiasis in Caroli's syndrome.
Topics: Adult; Bile Duct Diseases; Bile Ducts, Intrahepatic; Caroli Disease; Cholelithiasis; Female; Follow-Up Studies; Humans; Liver Function Tests; Male; Ultrasonography; Ursodeoxycholic Acid | 1993 |
Early hepatobiliary dysfunction during total parenteral nutrition: an experimental study.
Topics: Animals; Bile Acids and Salts; Bile Duct Diseases; Cholesterol; Female; Liver Diseases; Parenteral Nutrition, Total; Rabbits; Sulfobromophthalein; Time Factors; Ursodeoxycholic Acid | 1993 |
Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid.
Topics: Adrenal Cortex Hormones; Bile Duct Diseases; Bilirubin; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Fibrosis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Liver Diseases; Male; Severe Combined Immunodeficiency; Skin Diseases; Ursodeoxycholic Acid | 1997 |
Ursodeoxycholic acid in the treatment of AIDS-associated cholangiopathy.
Topics: Acquired Immunodeficiency Syndrome; Bile Duct Diseases; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Humans; Pilot Projects; Ursodeoxycholic Acid | 1997 |
Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child.
Topics: Acute Disease; Adult; Bile Duct Diseases; Biopsy; Child; Cholestasis; Female; Humans; Ibuprofen; Liver; Liver Cirrhosis; Prednisone; Stevens-Johnson Syndrome; Tacrolimus; Time Factors; Ursodeoxycholic Acid | 1998 |
[Ursodeoxycholic acid as the main treatment of hepatobiliary diseases in children and teenagers].
Topics: Adolescent; Bile Duct Diseases; Child; Humans; Liver Diseases; Ursodeoxycholic Acid | 2001 |
[ESWL therapy of patients with gallstone].
Topics: Bile Duct Diseases; Chenodeoxycholic Acid; Cholelithiasis; Combined Modality Therapy; Humans; Lithotripsy; Ursodeoxycholic Acid | 1992 |
[Effects of biliary lithogenesis in acromegalic patients with long-term octreotide (SMS 201-995) treatment].
Topics: Acromegaly; Adult; Aged; Bile Duct Diseases; Cholelithiasis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Octreotide; Risk Factors; Ultrasonography; Ursodeoxycholic Acid | 1991 |
[Medical treatment of biliary lithiasis].
Topics: Bile Duct Diseases; Chenodeoxycholic Acid; Cholelithiasis; Deoxycholic Acid; Humans; Ursodeoxycholic Acid | 1987 |